GUILHERME HENRIQUE PEIXOTO DE OLIVEIRA

(Fonte: Lattes)
Índice h a partir de 2011
4
Lattes
Projetos de Pesquisa
Unidades Organizacionais

Filtros

Limpar filtros

Configurações

Autor e Coautores FMUSP-HC Normalizados: MATHEUS DE OLIVEIRA VERAS ×

Resultados de Busca

Agora exibindo 1 - 4 de 4
  • conferenceObject
    HOT VERSUS COLD SNARE FOR COLORECTAL POLYPECTOMIES SIZED UP TO 10MM. A SYSTEMATIC REVIEW AND META-ANALYSIS
    (2023) CAVASSOLA, Paulo; HIRSCH, Bruno Salomao; BESTETTI, Alexandre; OLIVEIRA, Guilherme Henrique Peixoto de; GOMES, Romulo; VERAS, Matheus; BERNARDO, Wanderley; MOURA, Diogo De; MOURA, Eduardo De
  • conferenceObject
    ENDOSCOPIC ULTRASOUND-ASSISTED BY ARTIFICIAL INTELLIGENCE FOR DIAGNOSIS OF GASTROINTESTINAL SUBEPITHELIAL LESIONS: SYSTEMATIC REVIEW AND META-ANALYSIS
    (2023) GOMES, Romulo; OLIVEIRA, Guilherme Henrique Peixoto de; SASSO, Joao Guilherme Ribeiro Jordao; KOTINDA, Ana Paula; MATSUBAYASHI, Carolina; VERAS, Matheus; BERNARDO, Wanderley; CAVASSOLA, Paulo; MOURA, Eduardo De
  • conferenceObject
    HOT VERSUS COLD SNARE FOR COLORECTAL POLYPECTOMIES SIZED UP TO 10MM. A SYSTEMATIC REVIEW AND META-ANALYSIS
    (2023) CAVASSOLA, Paulo; HIRSCH, Bruno Salomao; BESTETTI, Alexandre; OLIVEIRA, Guilherme Henrique Peixoto de; GOMES, Romulo; VERAS, Matheus; BERNARDO, Wanderley; MOURA, Diogo De; MOURA, Eduardo De
  • article
    Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis
    (2024) VERAS, Matheus de Oliveira; MOURA, Diogo Turiani Hourneaux de; MCCARTY, Thomas R.; OLIVEIRA, Guilherme Henrique Peixoto de; GOMES, Romulo Sergio Araujo; LANDIM, Davi Lucena; NUNES, Felipe Giacobo; FRANZINI, Tomazo Antonio Prince; SANTOS, Marcos Eduardo Lera dos; BERNARDO, Wanderley Marques; MOURA, Eduardo Guimaraes Hourneaux de
    Background and study aims Recurrent biliary stent occlusion and tumor ingrowth remain a major concern among patients with malignant biliary obstruction (MBO) with significant impact on patient morbidity and survival. Intraductal radiofrequency ablation (RFA) has emerged as a promising treatment that seeks to extend stent patency. This study aimed to evaluate the impact of RFA on overall survival (OS) and stent patency among patients with unresectable MBO.Methods A comprehensive search of electronic databases was performed for randomized controlled trials (RCTs) comparing RFA plus biliary stent (RFA+S) versus biliary stent alone (S-alone). Outcomes assessed included overall survival, stent patency, and adverse events (AEs) with mean difference (MD) calculated from pooled proportions. Subgroup analyses were performed for hilar strictures and cholangiocarcinoma (CCA).Results Six RCTs (n=439 patients) were included and demonstrated improved survival among patients who received RFA+S (MD 85.80 days; 95% confidence interval [CI] 35.02-136.58; I 2 =97%; P <0.0009). The pooled MD for total stent patency was 22.25 days (95% CI 17.38-61.87; I (2) =97%; P =0.27). There was no difference in AEs between RFA+S vs S-alone ( P >0.05). On subgroup analyses, RFA+S was associated with improved stent patency (MD 76.73 days; 95% CI 50.11-103.34; I 2 =67%; P <0.01) and OS (MD 83.14 (95% CI 29.52-136.77; I- 2 =97%; P <0.01] for CCA. For hilar strictures, stent patency was improved among patients with RFA+S [MD 83.71 days (95% CI 24.85-142.56; I 2 =84%; P <0.01].Conclusions RFA+S improved OS in the treatment of MBO when compared with S-alone. Moreover, the RFA therapy prolonged stent patency in hilar strictures and CCA, with similar rates of AEs.